Result Summary for 113377
|Clinical Study ID:||AC4113377|
|Official Title:||Phase I study of GSK573719 -A randomized, double blind, placebo controlled, dose ascending, single and repeat dose study to investigate the safety, tolerability, and pharmacokinetics of inhaled dose of GSK573719 from a novel dry powder device in healthy Japanese male subjects -|
|Study Indications or Diseases:||
|Generic Name:||umeclidinium bromide|
|Trade/Product Name:||umeclidinium bromide|
|Approved Drug Label:||http://www.gsk.com/products.html|
|Results Summary:|| Click
here to download result summary.
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.